Investors Research Corp Atreca, Inc. Transaction History

Investors Research Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	BUY	$0.91 - $1.82 $113 - $227	125 Added 166.67%	200 $0
Q3 2021 Oct 27, 2021	BUY	$4.91 - $9.07 $73 - $136	15 Added 25.0%	75 $0
Q1 2021 Apr 28, 2021	SELL	$13.0 - $19.34 $65 - $96	-5 Reduced 7.69%	60 $1,000
Q3 2020 Oct 20, 2020	BUY	$12.67 - $23.19 $823 - $1,507	65 New	65 $1,000

30.6K

Ticker BCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,876,000
Description
Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified using its discovery platform. The company's ATRC-10...

Get notified when there are updates to the investment portfolio of Investors Research Corp, based on Form 13F filings with the SEC.

Stay updated on Investors Research Corp with notifications on news.